GNA11 and neoplasm: In contrast, the tumor-associated somatic Q209L Gα11 mutation led to both significantly (p < 0.0001) increased basal and maximal phospho-ERK fold-change responses when compared with the ADH2 mutants or WT Gα11, consistent with a constitutive up-regulation of MAPK signaling (Fig. 4, A and B).